Balloon catheter treatment for intermittent atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a new catheter-based treatment for paroxysmal atrial fibrillation (AF) — a type of irregular heartbeat that comes and goes. It uses a special balloon catheter to deliver energy to the heart to help restore a normal rhythm. This may be an option if medications haven't controlled your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 80 years old.
- You have had at least two episodes of symptom-causing atrial fibrillation in the last 6 months, and at least one episode confirmed by an ECG in the last year.
- Your AF episodes last less than 7 days at a time.
- You have tried at least one heart rhythm medication (like a beta-blocker or calcium channel blocker) and it didn't work, caused side effects, or you can't take it.
- You must be able to take blood thinners for at least 3 weeks before the procedure.
- You cannot have had a prior ablation, heart surgery, or certain heart procedures like valve repair.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter and system for people who have had one previous ablation for atrial fibrillation but still have symptoms. It aims to see if a repeat procedure can safely and effectively treat recurrent episodes.
This study tests a procedure called cryoballoon ablation that freezes the tissue causing irregular heartbeats. It is for people with intermittent atrial fibrillation who have not had this procedure before.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
This trial tests a new balloon catheter that uses pulsed electric fields to treat persistent atrial fibrillation, a type of irregular heartbeat that lasts more than 7 days. The treatment aims to restore normal heart rhythm and may be an option for people who have not had prior heart procedures.
This trial studies a heart procedure using the Affera SpherePVI system to treat paroxysmal (comes and goes) or persistent atrial fibrillation. It’s for people who still have symptoms despite at least one anti-arrhythmia medicine, and who are good candidates for catheter ablation.
This trial tests a balloon catheter that uses pulsed field energy to treat atrial fibrillation (AF) in people who have tried medication without success. It aims to see how well it works in real-world use.
Hear when a new Paroxysmal Atrial Fibrillation (PAF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.